IRIS UniCatt

Tursi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.010
AS - Asia 826
EU - Europa 555
SA - Sud America 210
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 960
SG - Singapore 399
CN - Cina 175
BR - Brasile 156
IT - Italia 141
DE - Germania 87
FR - Francia 82
VN - Vietnam 72
SE - Svezia 62
GB - Regno Unito 39
JP - Giappone 34
CA - Canada 31
IE - Irlanda 30
FI - Finlandia 29
ID - Indonesia 28
IN - India 23
KR - Corea 23
AR - Argentina 22
BD - Bangladesh 22
PL - Polonia 15
UA - Ucraina 15
CO - Colombia 11
HK - Hong Kong 11
RU - Federazione Russa 11
EC - Ecuador 10
MX - Messico 9
ES - Italia 8
NL - Olanda 8
BE - Belgio 6
PK - Pakistan 6
AT - Austria 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
SA - Arabia Saudita 5
MA - Marocco 4
TR - Turchia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
PY - Paraguay 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
PR - Porto Rico 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
JO - Giordania 1
LI - Liechtenstein 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.626
Salva come PNG Salva come JPEG
Città #
Singapore 240
San Jose 114
Ashburn 102
Chandler 97
New York 71
Los Angeles 51
Hefei 45
Beijing 41
Tokyo 33
Buffalo 29
Frankfurt am Main 29
Dublin 28
The Dalles 27
Ho Chi Minh City 26
Milan 26
Munich 23
Jakarta 22
Seoul 22
Council Bluffs 21
Lauterbourg 20
Paris 17
Rome 17
Hanoi 13
Helsinki 13
Marseille 13
Boardman 11
Brooklyn 11
Chicago 11
Hong Kong 11
Kent 11
Nuremberg 11
Santa Clara 11
São Paulo 11
Toronto 11
Warsaw 11
Boston 10
Bogotá 8
Dallas 8
Houston 8
Montreal 8
Pune 8
Turku 8
Jacksonville 7
North Bergen 7
Princeton 7
Seattle 7
Brussels 6
London 6
Memphis 6
Orem 6
Wilmington 6
Bari 5
Charlotte 5
Chennai 5
Curitiba 5
Fairfield 5
Lappeenranta 5
Poplar 5
Portsmouth 5
Appignano 4
Baghdad 4
Brasília 4
Dhaka 4
Guarulhos 4
Madrid 4
Moscow 4
Naples 4
Phoenix 4
Quito 4
Redwood City 4
Rio de Janeiro 4
San Francisco 4
Stockholm 4
Albiate 3
Ann Arbor 3
Belo Horizonte 3
Biên Hòa 3
Buenos Aires 3
Cairo 3
Campinas 3
Caxias do Sul 3
Chelsea 3
Düsseldorf 3
Florence 3
Harrison 3
Hyderabad 3
Johannesburg 3
Lahore 3
Las Vegas 3
Manaus 3
Monte Argentario 3
Mumbai 3
Ribeirão Preto 3
San Diego 3
San Mateo 3
Tashkent 3
Verona 3
Washington 3
Addis Ababa 2
Algiers 2
Totale 1.541
Salva come PNG Salva come JPEG
Nome #
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 224
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 159
Effect of moderate and heavy alcohol consumption on intestinal transit time 133
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 131
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 122
Microbiota Composition in Diverticular Disease: Implications for Therapy 119
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 119
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 113
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 105
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 103
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 102
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 102
Microbiota Composition in Diverticular Disease: Implications for Therapy 100
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 99
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 97
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 93
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 90
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 88
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 86
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 84
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 78
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 76
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 72
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 59
Response to Jackson et al 59
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 57
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 1
Totale 2.671
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202281 3 2 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025557 13 10 45 20 46 13 21 19 46 77 139 108
2025/20261.310 201 54 108 194 211 56 175 48 69 105 45 44
2026/2027156 156 0 0 0 0 0 0 0 0 0 0 0
Totale 2.671